Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 223 (RNA5SP223)

Target
RNA5SP223
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 223 (RNA5SP223) is a human pseudogene that resembles the 5S ribosomal RNA gene but is no longer functional due to sequence defects or mutations. It does not code for a functional RNA or protein and is not involved in normal ribosome biogenesis or cellular biological activities. Pseudogenes such as RNA5SP223 are generally considered "genomic fossils" and do not serve as drug targets or biomarkers, though rare pseudogenes may exert regulatory effects on gene expression by acting as competing endogenous RNAs or through other non-coding RNA mechanisms. No such role is established for RNA5SP223. This entity is not a receptor, enzyme, transporter, or any established therapeutic target class—it is a pseudogene. Pseudogenes are non-functional DNA sequences that derive from once-functional genes but have lost their coding potential, commonly due to mutations. The parental 5S ribosomal RNA gene encodes a non-coding RNA important for ribosome structure and function; however, pseudogenes such as RNA5SP223 do not perform this function. RNA, 5S ribosomal pseudogene 223 has not been implicated in disease or therapy and is not associated with any drugs or mechanisms of therapeutic action. In summary, RNA5SP223 is a nonfunctional ribosomal RNA pseudogene in humans, not an active biological target, not involved in coding protein or RNA, and has no current relevance as a drug target, biomarker, or disease role.

Other names
RN5S223RNA5SP223RNA, 5S ribosomal 223
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it is non-functional; parental 5S rRNA gene is involved in ribosome structure, but the pseudogene does not contribute)
04

Disease associations

None directly attributed. In rare cases, pseudogenes may play a role in disease through regulatory effects, but RNA5SP223 is not reported as such
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 223 (RNA5SP223).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 223 (RNA5SP223).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call